Enzon Pharmaceuticals, Inc. (ENZN) Swings to Q1 Loss
Tweet
Share
E-mailGet Alerts ENZN Hot Sheet
Price: $4.35 --0%
Financial Fact:
Total operating expenses: 200K
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Total operating expenses: 200K
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) reported Q1 EPS of ($0.02), versus $0.01 reported last year. Revenue for the quarter came in at $10.6 million, versus $18.02 million reported last year.
For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.
For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- C1 Fund reports portfolio growth and share repurchase activity
- Criterium Energy signs gas sales deal with PGN, reports Q2 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
